RESULTS OF IMPORT SUBSTITUTION ANALYSIS OF ANTI-CANCER MEDICATIONS IN THE RUSSIAN FEDERATION (2013–2018)
https://doi.org/10.19163/2307-9266-2019-7-2-105-111
Abstract
The aim. Due to the social importance of anticancer drugs, the aim of the study is to conduct a comparative analysis of the range of domestic and foreign anticancer medications included in the Lists of Vital and Essential Drugs in 2013 and 2018 in the aspect of import substitution.
Materials and methods. The study was conducted by comparing the data on the registered anticancer preparations included in the list of Vital and Essential Drugs in the State Register of Medicines in 2013 and 2018. Statistical processing of the data was carried out on the basis of Fisher Z-test method.
Results. All in all, there were 286 trade names of anticancer drugs registered in the Russian Federation in 2013. 94 of them, i.e. 33%, were Russian-made. In 2013, there were 19 pharmaceutical substances of domestic production in the analyzed group, which accounted for 27% of 71 INNs (International nonproprietary name). As for 71 INNs, in 2018 there were 393 registered trade names of anticancer drugs. 162 drugs, i.e. 41%, were Russian-made. From 2013 to 2018, a statistically significant positive trend of the increase in the number of domestic anticancer drugs by 8% was revealed.
Conclusion. In order to increase the volume of import substitution in the production of anticancer drugs, it is necessary to provide state support to Russian manufacturers, who register domestic analogues for the first time. A particular attention should be paid to the production of domestic pharmaceutical substances, without which it is impossible to ensure the drug safety of the country.
About the Authors
O. A. Ryzhova
Irkutsk State Medical Academy of Postgraduate Education – Branch of the Russian Medical Academy of Continuous Professional Training
Russian Federation
Russian Federation
Olga A. Ryzhova – Candidate of Sciences (Pharmacy), docent of the Department of Pharmacy
100, Yubileynyiy microdistrict, Irkutsk, 664049
T. L. Moroz
Irkutsk State Medical Academy of Postgraduate Education – Branch of the Russian Medical Academy of Continuous Professional Training
Russian Federation
Russian Federation
Tatyana L. Moroz – Doctor of Sciences (Pharmacy), Professor of the Department of Pharmacy
100, Yubileynyiy microdistrict, Irkutsk, 664049
References
1. Federal Law of 12 Apr 2010 N 61-FZ «On Circulation of Medicines». URL:http://www.consultant.ru/document/cons_doc_LAW_99350. Russia.
2. The order of Ministry of health of the Russian Federation of 13 Feb.2013 N 66 «About the approval of Strategy of provision of medicines of the population of the Russian Federation for the period till 2025 and the plan of its implementation». URL: http://www.consultant.ru/document/cons_doc_LAW_179288. Russian.
3. The order of the Ministry of industry and trade of the Russian Federation from 23 Oct 2009 N 965 «On approval of the strategy for the development of the pharmaceutical industry of the Russian Federation for the period up to 2020» URL:http://www.garant.ru/products/ipo/prime/doc/4089282/?prime. Russian.
4. Loginova LV, Petrukhina IK. Analiz assortimenta zhiznenno neobhodimyh i vazhnejshih lekarstvennyh preparatov, vypuskaemyh farmacevticheskoj promyshlennost’yu Privolzhskogo federal’nogo okruga [Analysis of assortment of vital and essential medicines produced by the pharmaceutical industry of Volga federal district]. Izvestija Samarskogo nauchnogo centra RAN. 2015;17,5(3):954-8. Russian.
5. Shirokova I, Progeria J, Bikbova M. Importozameshchenie daet nadezhdu onkologicheskim pacientam [Import substitution gives hope to cancer patients]. Remedium. 2017;7-8: 25-7. Russian.
6. The order of the Government of the Russian Federation of July 30, 2012 N 1378-r «On establishing a list of essential and essential medicines for 2013». URL: http://base.garant.ru/70105178. Russian.
7. The order of the Government of the Russian Federation of 23 Oct 2017 No. 2323-r «On the approval of the list of vital and essential drugs for 2018, the list of drugs for medical use, the list of drugs intended to provide persons with hemophilia, cystic fibrosis, pituitary nanism, Gaucher disease, malignant neoplasms of lymphoid, hematopoietic and related tissues , multiple sclerosis, as well as persons after transplantation of organs and (or) tissues, as well as the minimum range of drugs required health care». URL:https://rg.ru/2017/10/25/pravitelstvo-rasp2323-site-dok.html. Russian.
8. Analytical report. Russian pharmaceutical market. The 2013 DSM – Group, M.: DSM group, 2014. Russian.
9. Analytical report. Russian pharmaceutical market. The 2017 DSM – Group, M.: DSM group, 2018. Russian.
Review
For citations:
Ryzhova O.A., Moroz T.L. RESULTS OF IMPORT SUBSTITUTION ANALYSIS OF ANTI-CANCER MEDICATIONS IN THE RUSSIAN FEDERATION (2013–2018). Pharmacy & Pharmacology. 2019;7(2):105-111. https://doi.org/10.19163/2307-9266-2019-7-2-105-111
Views:
1084
Email this article 